CTXR Citius Pharmaceuticals, Inc.
0.5011USD+4.24%Mkt Cap: 13.76M $P/E: —1d ago
Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA-approved product, is a targeted immunotherapy for the treatment o…
Industry Peers
Biotechnology$128.08BUSDP/E 29.4
$78.44BUSD
$76.40BUSDP/E 18.4
$57.03BUSDP/E 37.3
$58.08BUSDP/E 35.4
$42.24BUSDP/E 18.0
$43.05BUSD
$41.41BUSDP/E 65.1
$32.80BUSDP/E 30.2
$30.03BUSDP/E 37.8
$25.10BUSD
$23.93BUSD
$22.99BUSDP/E 14.5
$22.27BUSDP/E 30.7
$22.54BUSDP/E 28.9
$22.22BUSD
$15.03BUSDP/E 17.5
$15.01BUSDP/E 15.8
$14.48BUSDP/E 18.4
$14.32BUSD
Key Statistics
Company
Market Cap13.76M USD
Enterprise Value12.66M USD
Revenue (TTM)7.11M USD
Gross Profit5.50M USD
Net Income (TTM)-37.43M USD
Revenue/Share0.33 USD
Last Price0.5011 USD
Fiscal Year EndSep 2025
MR QuarterJun 2026
Employees23
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.33
PEG—
EV/EBITDA—
EV/Revenue1.78
P/S1.86
P/B0.20
EPS (TTM)-1.75
EPS (Forward)-1.44
52W Range
0.46912% of range2.190
52W High2.190 USD
52W Low0.4691 USD
Profitability
Gross Margin77.34%
Oper. Margin-670.23%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-55.42%
ROA-28.59%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-26.55M USD
CapEx (TTM)—
FCF Margin-517.98%
FCF Yield-267.54%
Net Debt-9.83M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.03
Current Ratio0.84
Quick Ratio0.34
Book Value/Sh2.43 USD
Cash/Share0.62 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay DateJun 9, 2017
Splits
Last Split1:25
Split DateNov 26, 2024
Analyst Consensus
Rating—
Target (Mean)4.000 USD
Upside (mean)+698.2%
Target Range4.000 USD – 4.000 USD
# Analysts1
Ownership
Shares Out.27.45M
Float26.96M
Insiders1.80%
Institutions4.95%
Short Interest
Short Ratio9.5d
Short % Float20.63%
Short % Out.20.26%
Shares Short5.56M
Short (prev mo.)5.37M
Technical
SMA 500.5998 (-16.5%)
SMA 2000.6990 (-28.3%)
Beta1.00
S&P 52W Chg16.45%
Avg Vol (30d)350.60K
Avg Vol (10d)158.27K
Technical Indicators
RSI (14)39.6
MACD-0.0250
MACD Signal-0.0178
MACD Hist.-0.0072
BB Upper0.6252 USD
BB Middle0.5591 USD
BB Lower0.4930 USD
BB Width23.65%
ATR (14)0.0376 USD
Vol Ratio (20d)0.84x